Overview

Weight Adjusted Low Molecular Weight Heparin in Recurrent Implantation Failure: a Randomized Open Labeled Trial

Status:
Terminated
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Prospective randomized study of patients with infertility candidates to Assisted ReproductiveTechniques (ART), screened for all inclusion and exclusion criteria, submitted to ART cycle with or without low molecular weight heparin (LMWH) administration. Aims of the study are to evaluate, primarily, pregnancy rate/embryo transfer, secondarily take home babies/embryo transfer, implantation rate, and the role of thrombophilic factors
Phase:
Phase 3
Details
Lead Sponsor:
Istituto Clinico Humanitas
Treatments:
Dalteparin
Heparin
Heparin, Low-Molecular-Weight
Parnaparin